The 5-HT1A receptor: an overview of recent advances |
| |
| Authors: | Salah El Mestikawy Annick Fargin John R Raymond Henri Gozlan Mark Hnatowich |
| |
| Institution: | (1) INSERM U288, Neurobiologie cellulaire et fonctionnelle, Facultéde Médecine Pitié-Salpêtrière, Paris, France;(2) Dept. of Medicine (Cardiology), Duke University Medical Center, 27710 Durham, N.C., USA;(3) Department of Medicine (Nephrology), Duke University Medical Center, 27710 Durham, N.C., USA;(4) Department of Veterans Affairs Medical Center, 27710 Durham, N.C., USA;(5) Howard Hughes Medical Institute, 27710 Durham, N.C., USA |
| |
| Abstract: | Progress in the field of neuronal receptor research has accelerated during the last few years due to developments in pharmacology and molecular biology. This is particularly true in the case of the serotonin 5-HT1A receptor. In 1983 the very selective, high affinity 5-HT1A agonist 8-OH-DPAT was developed which allowed the pharmacology and distribution of the 5-HT1A receptor in the central nervous system of the rat and man to be extensively characterized. By 1987, the gene encoding this receptor protein was cloned and sequenced, allowing not only elucidation of its structure, but also better insight into the nature of its coupling to transmembrane signal transduction systems. Thus in a short period of time considerable knowledge has accumulated on how serotonin exerts its functions in the central nervous system via the 5-HT1A receptor. In the present review we will briefly discuss some of the latest developments regarding the 5-HT1A receptor. |
| |
| Keywords: | Serotonin 5-HT 5-HT receptor subtype 5-HT1 receptor 8-OH-DPAT receptor purification receptor cloning antipeptide antibodies |
| 本文献已被 SpringerLink 等数据库收录！ |
|
